Research Paper Volume 12, Issue 2 pp 1322—1331
Association of antinuclear antibodies with the risk of intracranial arterial stenosis
- 1 Department of Neurology, First Affiliated Hospital of Kangda College, Nanjing Medical University, Lianyungang, China
- 2 Department of Neurology, Qingdao Municipal Hospital, Qingdao Clinical Medical College, Nanjing Medical University, Qingdao, China
- 3 Department of Neurology, Huai’an First People’s Hospital, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, China
- 4 Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China
- 5 Department of Public Health and Preventive Medicine, Kangda College of Nanjing Medical University, Lianyungang, China
- 6 Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical Universtiy, Yantai, China
- 7 Department of Clinical Laboratory, Qingdao Municipal Hospital, Qingdao University, Qingdao, China
- 8 Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
received: October 11, 2019 ; accepted: December 25, 2019 ; published: January 21, 2020 ;https://doi.org/10.18632/aging.102685
How to Cite
Copyright © 2020 Sun et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The prevalence of intracranial arterial stenosis (IAS) as well as antinuclear antibody (ANA) positivity was found to be higher in Asians than that in the Western population. To investigate the relation of ANAs with IAS in patients with acute ischemic cerebrovascular disease, we enrolled 2492 patients with acute ischemic stroke or transient ischemic attack into the study. All the patients were categorized into 3 groups according to the IAS burden. Multinomial logistic regression analyses were used in statistical analysis. The positive rate of ANAs in the IAS ≥ 2 group was higher than that in the single IAS group and the no IAS group (p<0.001). The adjusted odds ratio (OR) for IAS ≥ 2 in ANAs-positive patients was 3.737 (95%CI=2.676-5.220, p<0.001) compared with the ANAs-negative patients. ANAs were associated with multiple IAS rather than single IAS in both male and female subgroups. Besides, ANAs were significantly associated with single and multiple IAS in individuals ≤ 60 years. However, ANAs were only associated with two or more IAS in two age groups (between 61 to 75 years and >75 years old). In summary, ANAs are associated with IAS in patients with acute ischemic cerebrovascular disease.